Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1-Reference-Cited by-同舟云学术

Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1

Published:2014-02-06 Issue:2 Volume:9 Page:e86924
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Caleca Laura,Putignano Anna Laura,Colombo Mara,Congregati Caterina,Sarkar Mohosin,Magliery Thomas J.,Ripamonti Carla B.,Foglia Claudia,Peissel Bernard,Zaffaroni Daniela,Manoukian Siranoush,Tondini Carlo,Barile Monica,Pensotti Valeria,Bernard Loris,Papi Laura,Radice Paolo

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Early-Onset Breast Cancer;J Peto;J Natl Cancer I,1991

2. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations;JD Fackenthal;Nat Rev,2007

3. A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition Genes;DF Easton;Am J Hum Genet,2007

4. Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control;R Janavičius;EPMA J,2010

5. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families;P Tonin;Nat Med,1996

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refinement of the assignment to the ACMG/AMP BS3 and PS3 criteria of eight BRCA1 variants of uncertain significance by integrating available functional data with protein interaction assays;Frontiers in Oncology;2023-04-24

2. A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report;Frontiers in Oncology;2023-03-21

3. Hereditary hemorrhagic telangiectasia: First demonstration of a founder effect in Italy; the ACVRL1 c.289_294del variant originated in the country of Bergamo 200 years ago;Molecular Genetics & Genomic Medicine;2022-05-27

4. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants;Genetics in Medicine;2022-01

5. Towards population-based genetic screenings for breast and ovarian cancer: A comprehensive review from economic evaluations to patient perspectives;The Breast;2021-08